Advertising Biotech Computer Distribution education Healthcare Hong Kong Investment Manila Medicine Pharmaceutical Philippines private equity SenseTime stock exchange Supplier Technology University Venture Capital
“Patient Capital” Nurtures Life Science Innovations: MingMed and Super Vision Featured as Selected Investment Stories in the HKIC’s Annual Report HONG KONG, July 17, 2026 /PRNewswire/ — Beyond Ventures, a Hong Kong-based venture capital firm, warmly congratulates the Hong Kong Investment Corporation Limited (HKIC) on the release of its highly encouraging 2025 Annual Report. The report reveals that in 2025, the HKIC recorded a total of investment income of over HK$6.4 billion while its cumulative projects expanded to more than 200 as of the end of June 2026. In the annual report, two outstanding life science enterprises co-invested by Beyond…
News Timeline:
Track the development of this news story across the Internet.